Edesa Biotech, Inc.
EDSA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $14 | $13 | $6 |
| - Cash | $11 | $12 | $14 | $2 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $2 | -$1 | $4 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$2 | -$2 | -$2 | -$2 |
| % Margin | – | – | – | – |
| Net Income | -$2 | -$2 | -$2 | -$2 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.32 | -0.25 | -0.3 | -0.48 |
| % Growth | -28% | 16.7% | 37.5% | – |
| Operating Cash Flow | -$2 | -$2 | -$2 | -$2 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$2 | -$2 | -$2 | -$2 |